A detailed history of Violich Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Violich Capital Management, Inc. holds 47,037 shares of PFE stock, worth $1.21 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
47,037
Previous 46,869 0.36%
Holding current value
$1.21 Million
Previous $1.31 Million 3.81%
% of portfolio
0.18%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $4,653 - $5,273
168 Added 0.36%
47,037 $1.36 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $381,877 - $438,517
14,750 Added 45.92%
46,869 $1.3 Million
Q4 2023

Jan 26, 2024

SELL
$26.13 - $33.94 $55,709 - $72,360
-2,132 Reduced 6.22%
32,119 $925,000
Q1 2022

Apr 25, 2022

BUY
$45.75 - $56.69 $28,090 - $34,807
614 Added 1.83%
34,251 $1.77 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $401,802 - $516,149
10,237 Added 43.75%
33,637 $1.45 Million
Q3 2020

Oct 19, 2020

SELL
$31.75 - $37.25 $25,400 - $29,800
-800 Reduced 3.31%
23,400 $859,000
Q4 2019

Jan 16, 2020

SELL
$32.92 - $37.36 $8,888 - $10,087
-270 Reduced 1.1%
24,200 $948,000
Q3 2019

Nov 06, 2019

SELL
$32.49 - $42.13 $32,490 - $42,130
-1,000 Reduced 3.93%
24,470 $879,000
Q2 2019

Jul 22, 2019

SELL
$36.98 - $41.52 $36,980 - $41,520
-1,000 Reduced 3.78%
25,470 $0
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $57,714 - $61,529
-1,750 Reduced 6.2%
26,470 $960,000
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $14,260 - $15,709
-460 Reduced 1.6%
28,220 $1.01 Million
Q2 2017

Aug 14, 2017

BUY
N/A
28,680
28,680 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Violich Capital Management, Inc. Portfolio

Follow Violich Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.